1. Home
  2. FET vs IMMX Comparison

FET vs IMMX Comparison

Compare FET & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

HOLD

Current Price

$53.64

Market Cap

645.5M

Sector

Industrials

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$8.42

Market Cap

629.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FET
IMMX
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
645.5M
629.3M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
FET
IMMX
Price
$53.64
$8.42
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$19.20
AVG Volume (30 Days)
124.3K
1.3M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
92.64
N/A
EPS
0.39
N/A
Revenue
$791,474,000.00
N/A
Revenue This Year
$7.35
N/A
Revenue Next Year
$6.95
N/A
P/E Ratio
$133.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.93
$1.94
52 Week High
$65.43
$11.61

Technical Indicators

Market Signals
Indicator
FET
IMMX
Relative Strength Index (RSI) 44.20 41.54
Support Level $48.86 $8.10
Resistance Level $63.59 $8.97
Average True Range (ATR) 2.65 0.75
MACD -0.28 -0.09
Stochastic Oscillator 45.66 23.37

Price Performance

Historical Comparison
FET
IMMX

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: